TSLP and allergic disease: Modulation of TSLP/TSLPR signaling by a soluble TSLPR fragment fused to the Fc fragment of immunoglobulin (TSLPR-Ig)14 or an anti-TSLP antibody15 reduced eosinophilic airway inflammation and allergen-induced bronchoconstriction, alleviating the severity of allergic diseases.